Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;96:1343-1350

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sokoloski, M. C.
Right arrow Articles by Waldo, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sokoloski, M. C.
Right arrow Articles by Waldo, A. L.

(Circulation. 1997;96:1343-1350.)
© 1997 American Heart Association, Inc.


Articles

Safety of Transvenous Atrial Defibrillation

Studies in the Canine Sterile Pericarditis Model

Mary C. Sokoloski, MD; Gregory M. Ayers, MD, PhD; Koichiro Kumagai, MD; Celeen M. Khrestian, BS; Shinichi Niwano, MD; ; Albert L. Waldo, MD

From the Divisions of Cardiology and Pediatric Cardiology, Case Western Reserve University/University Hospitals of Cleveland (Ohio) and InControl, Inc, Redmond, Wash (G.M.A.).

Correspondence to Albert L. Waldo, MD, Division of Cardiology, University Hospitals of Cleveland, 11000 Euclid Ave, Cleveland, OH 44106-5038.

Background It is recognized that a ventricular vulnerability period exists during which atrial shock delivery may induce a ventricular tachyarrhythmia. This study was designed to define the zone in which the ventricles are vulnerable to induction of ventricular tachyarrhythmia during delivery of atrial shocks in the sterile pericarditis canine model of atrial fibrillation.

Methods and Results Two days after creation of sterile pericarditis, 24 dogs underwent either a four-part or five-part ventricular vulnerability protocol during which atrial shocks were delivered between transvenous catheters, one in the distal coronary sinus and one in the right atrial appendage. The protocol included part 1, shocks during induced atrial fibrillation; parts 2 through 4, shocks delivered synchronously with the last ventricular beat of one of the following three ventricular pacing protocols: constant ventricular rates (S1S1), short-long-short cycles (S1S2S3-V), and ventricular premature beats (S1); and part 5, shocks delivered synchronously with the last R wave resulting from an atrially paced short-long-short cycle (S1S2S3-A). Ventricular tachyarrhythmia was induced 122 times: 2 of 665 shocks in two dogs in part 1, 29 of 786 shocks in nine dogs in part 2, 67 of 734 shocks in 15 dogs in part 3, 24 of 919 shocks in five dogs in part 4, and none in part 5. All ventricular proarrhythmia resulted from shocks delivered during the T wave of a preceding ventricular beat. No episodes of ventricular tachyarrhythmia were induced by atrial shocks synchronized to R waves with the previous RR at intervals above the QT+60 ms interval (absolute interval >320 ms), with one exception, at the QT+100 ms interval (absolute interval 360 ms).

Conclusions With transvenous electrode catheters used to deliver atrial shocks, life-threatening ventricular rhythms were induced but were limited to a specific zone defined by the QT interval.


Key Words: defibrillation • fibrillation • atrium




This article has been cited by other articles:


Home page
CirculationHome page
H.-F. Tse, C.-P. Lau, J. S. Sra, H. J. G. M. Crijns, N. Edvardsson, S. Kacet, and D. G. Wyse
Atrial Fibrillation Detection and R-Wave Synchronization by Metrix Implantable Atrial Defibrillator : Implications for Long-Term Efficacy and Safety
Circulation, March 23, 1999; 99(11): 1446 - 1451.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. J. J. Wellens, C.-P. Lau, B. Luderitz, M. Akhtar, A. L. Waldo, A. J. Camm, C. Timmermans, H.-F. Tse, W. Jung, L. Jordaens, et al.
Atrioverter: An Implantable Device for the Treatment of Atrial Fibrillation
Circulation, October 20, 1998; 98(16): 1651 - 1656.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. L. Waldo
Low-Energy Atrial Defibrillation : A Promising New Technique
Circulation, September 1, 1998; 98(9): 833 - 834.
[Full Text] [PDF]